These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
312 related items for PubMed ID: 3498533
21. Sensitivity to 5,10-dideazatetrahydrofolate is fully conserved in a murine leukemia cell line highly resistant to methotrexate due to impaired transport mediated by the reduced folate carrier. Zhao R, Gao F, Babani S, Goldman ID. Clin Cancer Res; 2000 Aug; 6(8):3304-11. PubMed ID: 10955817 [Abstract] [Full Text] [Related]
22. A novel class of genetic variants of the L1210 cell up-regulated for folate analogue transport inward. Isolation, characterization, and degree of metabolic instability of the system. Sirotnak FM, Moccio DM, Yang CH. J Biol Chem; 1984 Nov 10; 259(21):13139-44. PubMed ID: 6490649 [Abstract] [Full Text] [Related]
23. Tissue pharmacokinetics, inhibition of DNA synthesis and tumor cell kill after high-dose methotrexate in murine tumor models. Sirotnak FM, Donsbach RC, Dorick DM, Moccio DM. Cancer Res; 1976 Dec 10; 36(12):4672-8. PubMed ID: 1000510 [Abstract] [Full Text] [Related]
24. Increased accumulation of methotrexate by murine tumor cells in vitro in the presence of probenecid which is mediated by a preferential inhibition of efflux. Sirotnak FM, Moccio DM, Young CW. Cancer Res; 1981 Mar 10; 41(3):966-70. PubMed ID: 7459883 [Abstract] [Full Text] [Related]
25. Proposed mechanism of therapeutic selectivity for 9-beta-D-arabinofuranosyl-2-fluoroadenine against murine leukemia based upon lower capacities for transport and phosphorylation in proliferative intestinal epithelium compared to tumor cells. Barrueco JR, Jacobsen DM, Chang CH, Brockman RW, Sirotnak FM. Cancer Res; 1987 Feb 01; 47(3):700-6. PubMed ID: 3802076 [Abstract] [Full Text] [Related]
26. Contrasting effects of oncogene expression on two carrier-mediated systems internalizing folate compounds in Fisher rat 3T3 cells. Kühnel JM, Chiao JH, Sirotnak FM. J Cell Physiol; 2000 Sep 01; 184(3):364-72. PubMed ID: 10911368 [Abstract] [Full Text] [Related]
30. Dynamics of antifolate transport via the reduced folate carrier and the membrane folate receptor in murine leukaemia cells in vitro and in vivo. Mauritz R, Peters GJ, Kathmann I, Teshale H, Noordhuis P, Comijn EM, Pinedo HM, Jansen G. Cancer Chemother Pharmacol; 2008 Nov 01; 62(6):937-48. PubMed ID: 18283461 [Abstract] [Full Text] [Related]
32. Role of methylenetetrahydrofolate depletion in methotrexate-mediated intracellular thymidylate synthesis inhibition in cultured L1210 cells. Bunni M, Doig MT, Donato H, Kesavan V, Priest DG. Cancer Res; 1988 Jun 15; 48(12):3398-404. PubMed ID: 3370638 [Abstract] [Full Text] [Related]
33. Use of non-physiological buffer systems in the analysis of methotrexate transport in L1210 cells. Henderson GB, Zevely EM. Biochem Int; 1983 Apr 15; 6(4):507-15. PubMed ID: 6679721 [Abstract] [Full Text] [Related]
34. Structural design, biochemical properties, and evidence for improved therapeutic activity of 5-alkyl derivatives of 5-deazaaminopterin and 5-deazamethotrexate compared to methotrexate in murine tumor models. Sirotnak FM, Schmid FA, Otter GM, Piper JR, Montgomery JA. Cancer Res; 1988 Oct 15; 48(20):5686-91. PubMed ID: 3167828 [Abstract] [Full Text] [Related]